search
Back to results

Healthy Liver - Healthy Brain

Primary Purpose

Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease, NAFLD

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Diet Intervention
Sponsored by
University of Texas at Austin
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Metabolic Syndrome focused on measuring Neuroimaging, Liver, Low-carbohydrate, Diet

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • at least 40 years of age
  • English speakers
  • show a minimum of 5% hepatic triglyceride level on liver imaging
  • have not taken part in a weight loss/dietary intervention within 6 months
  • not currently adhering to a low-carbohydrate diet (e.g., Atkins, Paleo)

Exclusion Criteria:

  • younger than 40 years of age
  • have a history of neurological disease (e.g. stroke, seizure disorder)
  • psychiatric illness (e.g. schizophrenia, bipolar disorder)
  • harmful alcohol use (AUDIT-C score >5)
  • morbid obesity (BMI>40)
  • MRI contraindications

Sites / Locations

  • University of Texas at AustinRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Low-carbohydrate diet

Low-calorie diet

Arm Description

Participants assigned to the Low-carbohydrate diet will be instructed to limit carbohydrate intake to <30 g/d.

Participants assigned to the Low-calorie diet will be instructed to reduce their energy intake to match the LoCHO block (we are predicting ~1200 kcal/d for women and ~1500 kcal/d for men, following current recommendations for treatment of NAFLD).

Outcomes

Primary Outcome Measures

Decrease in Liver Fat
Hepatic triglyceride level will be assessed using liver 1H MRS.
Decrease in cerebral gluatamate
Cerebral glutamate levels will be measured using 1H MRS.

Secondary Outcome Measures

Full Information

First Posted
December 30, 2021
Last Updated
June 21, 2022
Sponsor
University of Texas at Austin
search

1. Study Identification

Unique Protocol Identification Number
NCT05216796
Brief Title
Healthy Liver - Healthy Brain
Official Title
Diet Intervention to Promote Liver and Brain Health in Adults With Non-alcoholic Fatty Liver Disease
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Recruiting
Study Start Date
May 18, 2022 (Actual)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
September 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Texas at Austin

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
People with liver disease report difficulties with attention and problem-solving skills. Diet plays an important role in the development of liver disease and/or pre-diabetes. The purpose of this study is to examine whether participation in a brief diet intervention (up to 3 weeks) can improve brain and liver health and function.
Detailed Description
The importance of liver function for brain and cognitive health is undeniable. Specifically, adults with chronic liver diseases such as non-alcoholic fatty liver disease (NAFLD), a factor of metabolic syndrome (MetS), experience a range of symptoms including problems with attention, problem solving skills and executive function. Importantly, diet plays a role in the development of NAFLD. The investigators propose to be the first to demonstrate that Metabolic syndrome-related brain vulnerability, in the form of elevated free cerebral glutamate, is related to hepatic triglyceride level, through experimental manipulation of liver fat and multiorgan imaging. The investigators seek to improve liver health by altering diet content in a block randomized feeding trial. The investigators selected a low-carbohydrate (<30 g/d) diet (LoCHO) to reduce liver fat and a low-calorie (LoCAL) diet as a control for weight loss. The investigators hypothesize that LoCHO diet will improve cognitive performance by improving liver health and thus, brain health. This work may provide a way to support brain function in MetS and delay cognitive decline.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease, NAFLD, Pre-diabetes
Keywords
Neuroimaging, Liver, Low-carbohydrate, Diet

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The investigators will employ a block randomization (n=10) between groups feeding trial where 100 participants will be assigned to receive either low-carbohydrate (LoCHO) or low-calorie (LoCAL) control diet for up to 3 weeks.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Low-carbohydrate diet
Arm Type
Experimental
Arm Description
Participants assigned to the Low-carbohydrate diet will be instructed to limit carbohydrate intake to <30 g/d.
Arm Title
Low-calorie diet
Arm Type
Active Comparator
Arm Description
Participants assigned to the Low-calorie diet will be instructed to reduce their energy intake to match the LoCHO block (we are predicting ~1200 kcal/d for women and ~1500 kcal/d for men, following current recommendations for treatment of NAFLD).
Intervention Type
Behavioral
Intervention Name(s)
Diet Intervention
Intervention Description
Meal will be prepared and delivered by SNAP Kitchen, which has 7 locations in Austin and offers 20+ options for low-carbohydrate and low-calorie meals, each meal available in different sizes varying in energy intake. Meals will be entered into the Nutrition Data System for Research (NDS-R) software to confirm low-calorie profile. Meals will be delivered to participants' homes twice a week.
Primary Outcome Measure Information:
Title
Decrease in Liver Fat
Description
Hepatic triglyceride level will be assessed using liver 1H MRS.
Time Frame
Liver fat will be measured at baseline (week 0) and after at least 2 weeks (up to 3 weeks) on the designated diet. The liver 1H MRS scans will happen during Visit 3 (baseline) and Visit 4 (at least 2 weeks on the diet).
Title
Decrease in cerebral gluatamate
Description
Cerebral glutamate levels will be measured using 1H MRS.
Time Frame
Cerebral glutamate will be measured at baseline (week 0) and after at least 2 weeks (up to 3 weeks) on the designated diet. The brain 1H MRS scans will happen during Visit 3 (baseline) and Visit 4 (at least 2 weeks on the diet).

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: at least 40 years of age English speakers show a minimum of 5% hepatic triglyceride level on liver imaging have not taken part in a weight loss/dietary intervention within 6 months not currently adhering to a low-carbohydrate diet (e.g., Atkins, Paleo) Exclusion Criteria: younger than 40 years of age have a history of neurological disease (e.g. stroke, seizure disorder) psychiatric illness (e.g. schizophrenia, bipolar disorder) harmful alcohol use (AUDIT-C score >5) morbid obesity (BMI>40) MRI contraindications
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Andreana Haley, PhD
Phone
5124717926
Email
haley@austin.utexas.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Isabelle Gallagher, BS
Phone
2624431982
Email
isabelle.gallagher@austin.utexas.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andreana Haley, PhD
Organizational Affiliation
Department of Psychology, University of Texas at Austin
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Texas at Austin
City
Austin
State/Province
Texas
ZIP/Postal Code
78712
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Andreana Haley, Ph.D.
Phone
512-471-7926
Email
neurolab.ut@gmail.com
First Name & Middle Initial & Last Name & Degree
Andreana Haley, PhD
First Name & Middle Initial & Last Name & Degree
Hirofumi Tanaka, PhD

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There is not a plan to make IPD available.
Citations:
PubMed Identifier
21367948
Citation
Browning JD, Baker JA, Rogers T, Davis J, Satapati S, Burgess SC. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr. 2011 May;93(5):1048-52. doi: 10.3945/ajcn.110.007674. Epub 2011 Mar 2.
Results Reference
background
PubMed Identifier
19634296
Citation
Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report. 2009 May 5;(13):1-7.
Results Reference
background
PubMed Identifier
22552897
Citation
Haley AP, Gonzales MM, Tarumi T, Tanaka H. Subclinical vascular disease and cerebral glutamate elevation in metabolic syndrome. Metab Brain Dis. 2012 Dec;27(4):513-20. doi: 10.1007/s11011-012-9306-x. Epub 2012 May 3.
Results Reference
background
PubMed Identifier
30725769
Citation
Oh R, Gilani B, Uppaluri KR. Low-Carbohydrate Diet. 2023 Aug 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK537084/
Results Reference
background
PubMed Identifier
31314133
Citation
Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology. 2020 Jan;71(1):306-333. doi: 10.1002/hep.30866. No abstract available.
Results Reference
background

Learn more about this trial

Healthy Liver - Healthy Brain

We'll reach out to this number within 24 hrs